SERVIER RUS is a high tech production facility in Moscow that employs over 200 highly-skilled specialists, and operates in full compliance with the Good Manufacturing Practices (GMP). Today, over 90% of Servier's original medicines are produced at this plant.
Servier mostly produces medicines for the treatment of common, chronic, non-communicable diseases, such as cardiovascular diseases, diabetes mellitus, and chronic venous insufficiency. Demand for these medicines is growing continuously in Russia. In the 2018/2019 fiscal year alone, the facility's output increased by 13.4%, producing 40.9 million packages.